Mainz Biomed BV
NASDAQ:MYNZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Mainz Biomed BV
Effect of Foreign Exchange Rates
Mainz Biomed BV
Effect of Foreign Exchange Rates Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Effect of Foreign Exchange Rates | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Mainz Biomed BV
NASDAQ:MYNZ
|
Effect of Foreign Exchange Rates
-$146.1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
BioNTech SE
NASDAQ:BNTX
|
Effect of Foreign Exchange Rates
-€21.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
CureVac NV
NASDAQ:CVAC
|
Effect of Foreign Exchange Rates
€1m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
|
Immatics NV
NASDAQ:IMTX
|
Effect of Foreign Exchange Rates
-€16.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
|
Immunic Inc
NASDAQ:IMUX
|
Effect of Foreign Exchange Rates
$205k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Biotest AG
XETRA:BIO
|
Effect of Foreign Exchange Rates
-€100k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Mainz Biomed BV
Glance View
Mainz Biomed BV operates as a biotechnology company. The company is headquartered in Mainz, Hessen. The company went IPO on 2021-11-04. The firm operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The firm competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
See Also
What is Mainz Biomed BV's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
-146.1k
USD
Based on the financial report for Dec 31, 2024, Mainz Biomed BV's Effect of Foreign Exchange Rates amounts to -146.1k USD.
What is Mainz Biomed BV's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 5Y
-37%
Over the last year, the Effect of Foreign Exchange Rates growth was 68%.